DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
2.590
0.00 (0.00%)
May 2, 2024, 2:00 PM EDT - Market open
DiaMedica Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$7.00
Upside
+170.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +208.88% | Apr 24, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $11 → $8 | Strong Buy | Maintains | $11 → $8 | +208.88% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 → $6 | Buy | Reiterates | $7 → $6 | +131.66% | Mar 21, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $7 | Hold → Buy | Upgrades | $7 | +170.27% | Jun 22, 2023 |
| Lake Street | Lake Street | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +208.88% | Jul 7, 2022 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $12 | Strong Buy | Maintains | $18 → $12 | +363.32% | Jul 7, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
| Roth Capital | Roth Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jun 30, 2021 |
| Oppenheimer | Oppenheimer | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 8, 2021 |
| Roth Capital | Roth Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Feb 17, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jul 8, 2020 |